Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: A cooperative study in Europe, Australia, and New Zealand

Journal of Neurosurgery

Volumn 84, Issue 2, 1996, Pages 221-228

  Kassell, Neal F ^a   Haley Jr , E Clarke ^a   Apperson Hansen, Carolyn ^a   Alves, Wayne M ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

21 aminosteroid; cerebral aneurysm; cerebral ischemia; subarachnoid hemorrhage; tirilazad

Indexed keywords

21 AMINOSTEROID; TIRILAZAD;

ADULT; AGED; ARTICLE; AUSTRALIA; BRAIN ARTERY ANEURYSM; BRAIN ISCHEMIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; EUROPE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MULTICENTER STUDY; NEW ZEALAND; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBARACHNOID HEMORRHAGE; VASOSPASM;

EID: 13344261979     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.1996.84.2.0221     Document Type: Article

References (22)

1. Asano T, Matsui T, Takuwa Y: Lipid peroxidation, protein kinase C, and cerebral vasospasm. Crit Rev Neurosurg 1: 361-379, 1991
2. Drake CG: Report of World Federation of Neurological Surgeons Committee on a universal subarachnoid hemorrhage grading scale. J Neurosurg 68:985-986, 1988
3. Fleishaker JC, Hulst-Pearson LK, Peters GR: Effect of gender and menopausal status on the pharmacokinetics of tirilazad mesylate in healthy subjects. Am J Thera 2:553-560, 1995
4. Fleishaker JC, Peters GR, Cathcart KS, et al: Evaluation of the pharmacokinetics and tolerability of tirilazad mesylate, a 21-aminosteroid free radial scavenger: I. Single-dose administration. J Clin Pharmacol 33:175-181, 1993
5. Fleishaker JC, Peters GR, Cathcart KS, et al: Evaluation of the pharmacokinetics and tolerability of tirilazad mesylate, a 21-aminosteroid free radical scavenger: II. Multiple-dose administration. J Clin Pharmacol 33:182-190, 1993
6. Haley EC Jr, Kassell NF, Alves WM, et al: Phase II trial of tirilazad in aneurysmal subarachnoid hemorrhage: a report of the Cooperative Aneurysm Study. J Neurosurg 82:786-790, 1995
7. Haley EC Jr, Kassell NF, Torner JC, et al: A randomized controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. J Neurosurg 78:537-546, 1993
8. Haley EC Jr, Kassell NF, Torner JC, et al: A randomized trial of two doses of nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. J Neurosurg 80:788-796, 1994
9. Hall ED, McCall JM, Means ED: Therapeutic potential of the lazaroids (21-aminosteroids) in acute central nervous system trauma, ischemia and subarachnoid hemorrhage. Adv Pharmacol 28:221-268, 1994
10. Hall ED, Travis MA: Effects of the nonglucocorticoid 21-aminosteroid U74006F on acute cerebral hypoperfusion following experimental subarachnoid hemorrhage. Exp Neurol 102:244-248, 1988
11. Jennett B, Bond M: Assessment of outcome after severe brain damage. A practical scale. Lancet 1:480-484, 1975
12. Jennett B, Teasdale G, Braakman R, et al: Prognosis of patients with severe head injury. Neurosurgery 4:283-289, 1979
13. Lyden P, Brott T, Tilley T, et al: Improved reliability of the NIH Stroke Scale using video training. Stroke 25:2220-2226, 1994
14. Neter J, Wasserman W, Kutner N: Applied Linear Statistical Models, Regression, Analysis of Variance, and Experimental Designs. Boston: RD Irwin, 1990, pp 587-589
15. Park CK, Hall ED: Dose-response analysis of the effect of 21-aminosteroid tirilazad mesylate (U-74006F) upon neurological outcome and ischemic brain damage in permanent focal cerebral ischemia. Brain Res 645:157-163, 1994
16. Schmidley JW: Free radicals in central nervous system ischemia. Stroke 21:1086-1090, 1990
17. Steinke DE, Weir BKA, Findlay JM, et al: A trial of the 21-aminosteroid U74006F in a primate model of chronic cerebral vasospasm. Neurosurgery 24:179-186, 1989
18. Vollmer DG, Kassell NF, Hongo K, et al: Effect of the nonglucocorticoid 21-aminosteroid U74006F on experimental cerebral vasospasm. Surg Neurol 31:190-194, 1989
19. Wilson JT, Bednar MM, McAuliffe TL, et al: The effect of the 21-aminosteroid U74006F in a rabbit model of thromboembolic stroke. Neurosurgery 31:929-934, 1992
20. World Medical Association Declaration of Helsinki: Recommendations Guiding Physicians in Biomedical Research Involving Human Subjects. Adopted by the 18th World Medical Assembly, Helsinki, Finland, June 1964; amended October 1975, October 1983, and September 1989
21. Xue D, Slivka A, Buchan AM: Tirilazad reduces cortical infarction after transient but not permanent focal cerebral ischemia in rats. Stroke 23:894-899, 1992
22. Zuccarello M, Marsch JT, Schmitt G, et al: Effect of the 21-aminosteroid U74006F on cerebral vasospasm following subarachnoid hemorrhage. J Neurosurg 71:98-104, 1989